Myriad Genetics, Inc. Share Price
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5.720 USD | +0.88% |
|
-4.98% | -6.99% |
| 11-10 | Myriad Genetics, Inc. Presents at 2026 UBS Global Healthcare Conference, Nov-10-2026 01:15 PM | |
| 11-05 | Myriad Genetics, Inc., Q3 2026 Earnings Call, Nov 04, 2026 |
| Market Cap | 549M 495M 457M 413M 781M 51.46B 801M 5.48B 2.18B 27.56B 2.06B 2.02B 87.71B | P/E 2026 * |
-3.45x | P/E 2027 * | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 500M 450M 416M 376M 712M 46.87B 729M 4.99B 1.99B 25.1B 1.88B 1.84B 79.88B | EV / Sales 2026 * |
0.64x | EV / Sales 2027 * | 0.65x |
| Free-Float |
96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MYGN | Delayed | |
CBOE
| MYGN | Real-time | |
|
Deutsche Boerse AG
| MYD | Delayed | |
|
Tradegate
| MYD | Real-time | |
|
Börse Stuttgart
| MYD | Delayed | |
|
Xetra
| MYD | Delayed | |
|
Boerse Muenchen
| MYD | Real-time |
Last Transcript: Myriad Genetics, Inc.
| 1 day | +0.88% | ||
| 1 week | -4.98% | ||
| Current month | -9.92% | ||
| 1 month | +32.71% | ||
| 3 months | +77.64% | ||
| 6 months | +35.87% | ||
| Current year | -6.99% |
| 1 week | 5.55 |  | 6.36 |
| 1 month | 3.95 | | 6.77 |
| Current year | 2.74 | | 7.15 |
| 1 year | 2.74 | | 8.08 |
| 3 years | 2.74 | | 29.3 |
| 5 years | 2.74 | | 30.54 |
| 10 years | 2.74 | | 50.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samraat Raha
CEO | Chief Executive Officer | 54 | 29/04/2025 |
Benjamin Wheeler
DFI | Director of Finance/CFO | 43 | 15/08/2025 |
Raj Jampa
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
S. Phanstiel
CHM | Chairman | 67 | 22/03/2020 |
Heiner Dreismann
BRD | Director/Board Member | 71 | 09/06/2010 |
Colleen Reitan
BRD | Director/Board Member | 66 | 24/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/11/26 | Free | General Counsel | 39,370 | 0.0412% | ||
| 21/09/26 | Tax | Chief Financial Officer | -2,555 | 0.0027% | ||
| 16/09/26 | Free | Executive/Senior Manager | 257,731 | 0.2695% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | -4.98% | -14.37% | -65.23% | 549M | |
| -1.06% | -5.38% | -13.94% | +16.30% | 189B | |
| +0.02% | -3.19% | +6.51% | +43.76% | 124B | |
| -1.70% | -6.14% | -12.35% | +16.51% | 121B | |
| -0.49% | -5.37% | -43.36% | +2.77% | 93.09B | |
| +0.34% | -1.16% | -4.16% | +77.09% | 66.77B | |
| +0.90% | +2.55% | +13.49% | -8.58% | 58.43B | |
| +0.85% | +0.58% | -1.39% | +63.88% | 55.35B | |
| +0.96% | +0.06% | -1.73% | +56.33% | 49.49B | |
| +2.24% | -3.22% | -5.15% | -7.41% | 34.53B | |
| Average | +0.27% | -2.59% | -7.65% | +19.54% | 79B | |
| Weighted average by Cap. | -0.25% | -3.10% | -9.08% | +27.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 785M 708M 654M 591M 1.12B 73.63B 1.15B 7.83B 3.12B 39.44B 2.95B 2.88B 125B | 738M 665M 614M 555M 1.05B 69.19B 1.08B 7.36B 2.93B 37.06B 2.77B 2.71B 118B |
| Net income | -158M -142M -131M -119M -224M -14.78B -230M -1.57B -627M -7.91B -591M -579M -25.18B | -126M -114M -105M -95.11M -180M -11.85B -184M -1.26B -503M -6.35B -474M -464M -20.2B |
| Net Debt | -48.99M -44.15M -40.79M -36.87M -69.76M -4.59B -71.49M -489M -195M -2.46B -184M -180M -7.83B | -67.76M -61.07M -56.42M -51.01M -96.5M -6.36B -98.88M -676M -270M -3.4B -254M -249M -10.83B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$5.720 | +0.88% | 1,379,312 |
| 10/11/26 | US$5.670 | -1.22% | 1,157,256 |
| 09/11/26 | US$5.740 | -3.04% | 2,059,687 |
| 06/11/26 | US$5.920 | -5.88% | 2,563,822 |
| 05/11/26 | US$6.290 | +4.49% | 3,599,453 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MYGN Stock
Select your edition
All financial news and data tailored to specific country editions
